SantoshSarafMD
Hematology • Chicago, ILAssociate Professor of Medicine, University of Illinois at Chicago
Dr. Saraf is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1740 W Taylor St
Dept 3462
Chicago, IL 60612Phone+1 312-704-2885Fax+1 312-704-2737
Education & Training
University of Illinois College of Medicine at ChicagoFellowship, Hematology and Medical Oncology, 2009 - 2012
MedStar Health/Georgetown University HospitalFellowship, Hematology and Medical Oncology, 2007 - 2007
Lewis Katz School of Medicine at Temple UniversityClass of 2003
Certifications & Licensure
IL State Medical License 2005 - 2026
DC State Medical License 2007 - 2008- American Board of Internal Medicine Hematology
Clinical Trials
- A Voxelotor for Sickle Cell Anemia Patients at Highest Risk for Progression of Chronic Kidney Disease Start of enrollment: 2021 Mar 16
- A Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vaso-occlusive Crises Start of enrollment: 2021 Oct 26
Roles: Principal Investigator
Publications & Presentations
PubMed
- Digital cognitive behavioral therapy vs education for pain in adults with sickle cell disease.Charles R Jonassaint, Christina M Lalama, C Patrick Carroll, Sherif M Badawy, Megan E Hamm
Blood Advances. 2024-12-24 - The use of abstract animations and a graphical body image for assessing pain outcomes among adults with sickle cell disease.Julia A O'Brien, Charles R Jonassaint, Ektha Parchuri, Christina M Lalama, Sherif M Badawy
The Journal of Pain. 2024-10-22 - Soluble urokinase plasminogen activator receptor is associated with kidney disease and its progression in sickle cell anemia.Rima S Zahr, Sara R Rashkin, Maria Armila Ruiz, Laila Elsherif, Guohui Ren
Haematologica. 2024-10-01
Abstracts/Posters
- Phase 1 Single (SAD) and Multiple Ascending Dose (MAD) Studies of the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of FT-4202, an Allosteric A...Santosh L. Saraf, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Impact of Intravenous Opioid Shortage on Managing Pain Crisis in Sickle Cell DiseaseSantosh L. Saraf, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Risk Factors for Kidney Disease in Hb SC and Hb S_+-Thalassemia Sickle Cell DiseaseSantosh L. Saraf, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Lectures
- Manifestations of Reduced Kidney Function Occur at a Higher Estimated Glomerular Filtration Rate in Sickle Cell Anemia61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Laboratory and Translational Hematology61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Regulatory Genetic Variation at the S100B Gene Associates with Vaso-Occlusive Manifestations in Sickle Cell Disease2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
TN Doctor Leading $3 Million AI Study for Predicting Kidney Function Decline in Sickle Cell PatientsOctober 30th, 2021- Alpha-1-Microglobulin and Acute Kidney Injury Associated with Sickle Cell DiseaseApril 7th, 2020
A Dire DiagnosisMarch 15th, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
